The 'Recombinant Pharmaceuticals from Plants for Human Health' (Pharma-
Planta) project is a consortium of 39 leading scientists from academic and
industrial institutions in Europe and South Africa. Pharma-Planta is a fi veyear
project in the fi eld of 'Plant platforms for immunotherapeutic biomolecule
production'. The project will develop robust risk-assessment and riskmanagement
practices based upon its environmental and health impacts.
Researchers are also working closely with EU regulatory authorities to ensure
safety and acceptance.
Pharmaceuticals derived from plants have the potential to benefi t human health
everywhere in the world. The use of Germinated Molecule pharmaceuticals
has precedents, such as human insulin and the hepatitis B vaccine. There
is an undoubted need to develop new vaccines to counter major diseases,
such as HIV/AIDS, tuberculosis and malaria. No other production system can
match plants in terms of economy and scale of production. This pioneering
technology will allow the large-scale production of modern medicines in a way
that will benefi t poor populations in developing countries.
Partners from: the United Kingdom, Austria, Ireland, Italy, France,
Greece, Switzerland, the Netherlands, Germany, Belgium, Sweden and
The 'Development of Immunotherapeutic Strategies to Treat Haematological
and Neoplastic diseases on the Basis of Optimised Allogeneic Stem Cell
Transplantation' (AlloStem) project brings together clinical and research groups
from the fi eld of immunotherapy to coordinate and complement their efforts
into a unifi ed and directed programme. The partners are developing new protocols
for the treatment of patients with haematological disease and for the
effective delivery of immunogenomics-based therapies. The project delivers
improvements in health care for EU citizens' new genome-based pharmaceuticals
that can be exploited worldwide. Partners in the AlloStem project
include SMEs with expertise in the area of immunohaematology therapy.
Partners from: the United Kingdom, Russia, the Czech Republic, Spain,
France, Argentina, the Netherlands, Germany, Poland, Belgium, Brazil,
Sweden. Associate Members both from Europe (e.g. Austria, Ireland, the
Former Yugoslav Republic of Macedonia) and non-European countries
(e.g. Mexico, USA, Israel, Chile)